COVID-19 Vaccines
Latest COVID-19 vaccine updates
- An additional dose of COVID-19 vaccine for spring 2025 is recommended for high-risk or priority populations.
- If you are not high-risk it is recommended to wait until fall 2025 to receive COVID-19 vaccine to ensure optimal protection against circulating strains.
- As per the Ontario Ministry of Heath, Novavax will not be available in Ontario for the 2024/2025 season.
Vaccine eligibility and doses
The Ontario Ministry of Health is recommending an additional dose of COVID-19 vaccine for previously vaccinated individuals who have completed their primary series and are at increased risk of COVID-19 infection, including:
- Adults 65 years of age and older:
- 80 years of age and older are recommended to receive an additional dose.
- 65 to 79 years of age may receive an additional dose.
- Adult residents of long-term care homes and congregate living settings for seniors.
- Individuals six months of age and older who are moderately to severely immunocompromised (due to an underlying condition or treatment).
- Individuals 55 years and older who identify as First Nations, Inuit, or Metis and their non-Indigenous household members who are 55 years and older.
Not previously vaccinated |
A primary series should not be initiated or completed in spring 2025, unless individuals are part of the high-risk or priority population. |
Previously vaccinated |
Only individuals who are part of the high-risk or priority populations are recommended to receive COVID-19 vaccine this spring. |
Individuals who are immunocompromised |
The following individuals are considered to be moderately to severely immunocompromised and are recommended to receive an additional dose this spring:
|
Re-vaccination |
Speak to your health care provider if you have received a hematopoietic stem cell transplant, hematopoietic cell transplant (autologous or allogeneic) or have had (CAR)-T-cell therapy after previous COVID-19 vaccination(s). Re-vaccination may be recommended due to loss of immunity following transplant or therapy. |
Where to get vaccinated
Eligible individuals six months and older can receive the COVID-19 vaccine at participating pharmacies and select health care providers. Most pharmacies book appointments ahead of time and some allow walk-ins. Check with your pharmacy or health care provider before you go.
Find a participating pharmacy near you
Limited Health Department COVID-19 vaccine clinic appointments are available only for eligible children six months to four years-old.
Homebound immunization for eligible clients |
If you or someone you know meets the above criteria, you may be eligible for COVID-19 vaccine homebound immunization. Some pharmacies offer homebound vaccination services, check with your local participating pharmacy. If you are unable to access COVID-19 vaccine homebound immunization through a pharmacy, please submit an online request for a homebound COVID-19 vaccine appointment. Limited appointments are available. Use our online form to request a homebound COVID-19 vaccine appointment |
Proof of vaccination and receipts
- Proof of COVID-19 vaccination is no longer required for businesses.
- Businesses can voluntarily implement a proof of COVID-19 vaccination requirement upon entry to their facility.
COVID-19 vaccine receipts | ||
|
||
Reporting vaccines received outside of Ontario or Canada | ||
Out of province entries requires a careful manual review, verification and data input by staff. Submissions with incomplete or unclear information, including errors may take additional time to process as they require additional follow-up with client or the organization where the vaccines were administered.
Please only complete this form if:
You can document individual COVID-19 vaccines or a full series. You will be required to submit proof of vaccination. Examples of proof include:
Some individuals vaccinated in Ontario received vaccine from what is referred to as non-Ontario stock. This refers to vaccine that was not allocated to Ontario or recorded in the provincial vaccine management system. Generally, these doses were delivered at institutions such as correctional facilities, military groups or embassies. Individuals who received doses of vaccine from the non-Ontario stock may also report out non-Ontario stock vaccinations to Durham Region Health Department using our online form. |
||
Requesting a name change on QR codes | ||
Name changes on your vaccine certificate |
Frequently asked questions about COVID-19 vaccines
Children six-months to under five-years old | ||||||||||||
|
||||||||||||
Children five to 11-years old | ||||||||||||
|
||||||||||||
General COVID-19 vaccine information | ||||||||||||
|
Medical and safety information | ||||||||||
|
Vaccine approval and clinical trial (testing) information |
How was Health Canada able to approve the COVID-19 vaccine so quickly? Creating a new vaccine can take years. The COVID-19 vaccine happened so quickly for many reasons including:
Health Canada developed a fast-track review process to assess COVID-19 vaccines. Vaccine manufacturers were able to submit research and new evidence for review by Health Canada as it becomes available and throughout clinic trials. Previously, all clinical trials had to be completed prior to applying for Health Canada approval. Health Canada has implemented greater scientific resources, so reviews are completed in a timely manner without compromising any standards for vaccine use in Canada.
Check out this video for more information about how the COVID-19 vaccine was developed. To learn more about COVID-19 vaccine and the approval process, visit Health Canada's website. |
Where can I get more information? |
|
Resources in other languages
COVID-19 communication resources | ontario.ca
Resources for Indigenous Peoples
The facts about COVID-19 vaccines
EnglishCree Inuktitut Objibwe Eastern
Contact Us